Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2024: Deals Listed by Company A-Z, Headline Value, Therapeutic Area, and Technology Type
08 mars 2024 07h44 HE
|
Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2024" report has been added to ResearchAndMarkets.com's offering.Joint Venture Deals in...
Bredis Healthcare Awarded South Korean Government Grant for Advancing Early Diagnosis of Alzheimer's Disease
22 août 2023 02h45 HE
|
Bredis Healthcare Inc.
Bredis Healthcare secures KRW 1.7 billion grant for advancing Alzheimer’s disease diagnosis from South Korean government’s Deep Tech TIPS programNovel platform has demonstrated detection of...
Global Bioelectronic Medicine Market Analysis, 2018-2028 - Rising Demand for Advanced Healthcare Products
28 juin 2023 04h53 HE
|
Research and Markets
Dublin, June 28, 2023 (GLOBE NEWSWIRE) -- The Global Bioelectronic Medicine Markets, 2018-2028 report has been added to ResearchAndMarkets.com's offering.The global bioelectronic medicine market is...
$19+ Billion Worldwide Printed Electronics Industry to 2031 - Increasing Demand from the Automotive Industry Drives Growth
20 janv. 2023 04h03 HE
|
Research and Markets
Dublin, Jan. 20, 2023 (GLOBE NEWSWIRE) -- The "Printed Electronics Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering. This report provides strategists,...
NeuroSigma Announces That a Team Led by UCLA Researchers Receives NIH Grant to Conduct a Multicenter Trial of eTNS for Pediatric ADHD
14 juin 2022 11h00 HE
|
NeuroSigma, Inc.
Double-blind randomized controlled trial will enroll up to 225 children at UCLA and Seattle Children’s Hospital NeuroSigma will provide Monarch eTNS Systems and funding for long-term follow-up ...
NeuroSigma Receives FDA Breakthrough Device Designation for Monarch eTNS System®
22 févr. 2022 11h00 HE
|
NeuroSigma, Inc.
LOS ANGELES, Feb. 22, 2022 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a bioelectronic medical device company, today announced FDA Breakthrough Device Designation for its Monarch eTNS System® for...
NeuroSigma Announces Promotion of Dr. Colin Kealey to President
11 janv. 2022 11h00 HE
|
NeuroSigma, Inc.
LOS ANGELES, Jan. 11, 2022 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a bioelectronic medical device company, today announced the promotion of Dr. Colin Kealey to President. NeuroSigma is the developer...
NeuroSigma Announces a $5 Million Equity Investment by KT Corporation
08 déc. 2021 05h00 HE
|
NeuroSigma, Inc.
Transaction follows the June 2021 announcement of a strategic digital health partnership between NeuroSigma and KTSignificant investment in NeuroSigma’s digital health and neuro-electronics platform ...
Electromedical Technologies and Nazarbayev University to Commence Landmark Alzheimer's Disease Research Program
29 juil. 2021 06h00 HE
|
Electromedical Technologies, Inc.
SCOTTSDALE, AZ, July 29, 2021 (GLOBE NEWSWIRE) -- Electromedical Technologies, Inc. (OTCQB: EMED) (the "Company"), a pioneer in the development and production of bioelectronic devices designed to...
Global Biohacking Market (2020 to 2027) - Share, Size, Trends, Industry Analysis Report
04 mars 2021 06h18 HE
|
Research and Markets
Dublin, March 04, 2021 (GLOBE NEWSWIRE) -- The "Biohacking Market Share, Size, Trends, Industry Analysis Report, By Type; By Product; By Application; By End Use; By Regions; Segment Forecast,...